Literature DB >> 15637735

Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin.

Gao-Ping Zhao1, Zong-Guang Zhou, Wen-Zhang Lei, Yong-Yang Yu, Cun Wang, Zhao Wang, Xue-Lian Zheng, Rong Wang.   

Abstract

AIM: Local recurrence after curative surgical resection for rectal cancer remains a major problem. Several studies have shown that incomplete removal of cancer deposits in the distal mesorectum contributes a great share to this dismal result. Clinicopathologic examination of distal mesorectum in lower rectal cancer was performed in the present study to assess the incidence and extent of distal mesorectal spread and to determine an optimal distal resection margin in sphincter-saving procedure.
METHODS: We prospectively examined sepecimens from 45 patients with lower rectal cancer who underwent curative surgery. Large-mount sections were performed to microscopically observe the distal mesorectal spread and to measure the extent of distal spread. Tissue shrinkage ratio was also considered. Patients with involvement in the distal mesorectum were compared with those without involvement with regard to clinicopathologic features.
RESULTS: Mesorectal cancer spread was observed in 21 patients (46.7%), 8 of them (17.8%) had distal mesorectal spread. Overall, distal intramural and/or mesorectal spreads were observed in 10 patients (22.2%) and the maximum extent of distal spread in situ was 12 mm and 36 mm respectively. Eight patients with distal mesorectal spread showed a significantly higher rate of lymph node metastasis compared with the other 37 patients without distal mesorectal spread (P = 0.043).
CONCLUSION: Distal mesorectal spread invariably occurs in advanced rectal cancer and has a significant relationship with lymph node metastasis. Distal resection margin of 1.5 cm for the rectal wall and 4 cm for the distal mesorectum is proper to those patients who are arranged to receive operation with a curative sphincter-saving procedure for lower rectal cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15637735      PMCID: PMC4205328          DOI: 10.3748/wjg.v11.i3.319

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Avoidance of rectovaginal fistula as a complication after low anterior resection for rectal cancer using a double-stapling technique.

Authors:  T Nakagoe; T Sawai; T Tuji; A Nanashima; H Yamaguchi; T Yasutake; H Ayabe
Journal:  J Surg Oncol       Date:  1999-07       Impact factor: 3.454

2.  'Close shave' in anterior resection.

Authors:  N D Karanjia; D J Schache; W R North; R J Heald
Journal:  Br J Surg       Date:  1990-05       Impact factor: 6.939

3.  Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision.

Authors:  J Hida; M Yasutomi; T Maruyama; K Fujimoto; T Uchida; K Okuno
Journal:  J Am Coll Surg       Date:  1997-06       Impact factor: 6.113

4.  Determining safe margin of resection in low anterior resection for rectal cancer.

Authors:  W O Kirwan; J Drumm; J M Hogan; C Keohane
Journal:  Br J Surg       Date:  1988-07       Impact factor: 6.939

5.  Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival.

Authors:  N S Williams; M F Dixon; D Johnston
Journal:  Br J Surg       Date:  1983-03       Impact factor: 6.939

6.  Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer.

Authors:  H Ueno; H Mochizuki; S Tamakuma
Journal:  Dis Colon Rectum       Date:  1998-01       Impact factor: 4.585

7.  Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer.

Authors:  N Scott; P Jackson; T al-Jaberi; M F Dixon; P Quirke; P J Finan
Journal:  Br J Surg       Date:  1995-08       Impact factor: 6.939

8.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

Review 9.  Results of radical surgery for rectal cancer.

Authors:  R J Heald; N D Karanjia
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  21 in total

Review 1.  The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.

Authors:  Jeremy R Parfitt; David K Driman
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

2.  Effect of preoperative chemotherapy on distal spread of low rectal cancer located close to the anus.

Authors:  Akihiro Kondo; Yuichiro Tsukada; Motohiro Kojima; Yuji Nishizawa; Takeshi Sasaki; Yasuyuki Suzuki; Masaaki Ito
Journal:  Int J Colorectal Dis       Date:  2018-09-13       Impact factor: 2.571

3.  Length of lymphangiogenesis in the rectal tissues distal to rectal cancer.

Authors:  Li-Ren Li; Yu-Jing Fang; Zhi-Zhong Pan; Xiao-Jun Wu; De-Sen Wan; Jennifer E Hardingham; Nicholas Rieger
Journal:  Tumour Biol       Date:  2010-08-03

4.  The clinical significance of distal spread differs according to the primary tumor location in rectal cancer.

Authors:  Kaoru Abe; Yoshifumi Shimada; Hidehito Oyanagi; Ryoma Yagi; Masato Nakano; Hitoshi Kameyama; Hitoshi Nogami; Satoshi Maruyama; Yasumasa Takii; Toshifumi Wakai
Journal:  Surg Today       Date:  2019-09-30       Impact factor: 2.549

Review 5.  Adequate length of the distal resection margin in rectal cancer: from the oncological point of view.

Authors:  In Ja Park; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2010-02-09       Impact factor: 3.452

Review 6.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

7.  [Problems in the treatment of upper rectal carcinoma].

Authors:  T Junginger; P Hermanek
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

8.  Clinical outcome of intersphincteric resection for ultra-low rectal cancer.

Authors:  Chih-Chien Chin; Chien-Yuh Yeh; Wen-Shih Huang; Jeng-Yi Wang
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

9.  Sphincter-preserving R0 total mesorectal excision with resection of internal genitalia combined with pre- or postoperative chemoradiation for T4 rectal cancer in females.

Authors:  Bartlomiej Szynglarewicz; Rafal Matkowski; Piotr Kasprzak; Daniel Sydor; Jozef Forgacz; Marek Pudelko; Jan Kornafel
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

10.  Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer.

Authors:  E Benzoni; D Intersimone; G Terrosu; V Bresadola; A Cojutti; F Cerato; C Avellini
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.